NCT01397006View on ClinicalTrials.gov

Fibromyalgia of Less Than One Year Duration. Study of Pregabalin

PHASE4WithdrawnINTERVENTIONAL
0
Timeline

Start Date

September 30, 2011

Primary Completion Date

March 31, 2014

Study Completion Date

March 31, 2014

Conditions
Fibromyalgia
Interventions
DRUG

Pregabalin

Pregabalin dose escalating every 2 weeks. Starting dose is 75 mg. Titrated up to maximum of 450mg

Trial Locations (1)

02462

Newton-Wellesley Hospital, Newton

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Newton-Wellesley Hospital

OTHER

NCT01397006 - Fibromyalgia of Less Than One Year Duration. Study of Pregabalin | Biotech Hunter | Biotech Hunter